Evidence map›Paper›PMID 42883983›Full record

ArticleInternational journal of molecular sciences2026

Distinct Superficial Epidermal Expression Patterns of IL-19 and IL-37 in Atopic Dermatitis.

Anna Zaryczańska, Krzysztof Sitko, Stefan Tukaj, Magdalena Trzeciak

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Anna ZaryczańskaDepartment of Dermatology, Venereology and Allergology, Medical University of Gdansk, 80-214 Gdansk, Poland.
Krzysztof SitkoDepartment of Plant Experimental Biology and Biotechnology, Faculty of Biology, University of Gdansk, 80-308 Gdansk, Poland.ORCID 0000-0001-7842-7555
Stefan TukajLaboratory of Cellular and Molecular Immunology, Department of Molecular Biology, Faculty of Biology, University of Gdansk, 80-308 Gdansk, Poland.
Magdalena TrzeciakDepartment of Dermatology, Venereology and Allergology, Medical University of Gdansk, 80-214 Gdansk, Poland.ORCID 0000-0002-8206-8441

Funding

Gdańsk Medical University 01-10026/0010438/01/253/253/0/2026National Science Centre 2020/37/N/NZ5/04208
6 · The paper itself

Abstract

Atopic dermatitis (AD) is characterized by heterogeneous immune activation extending beyond clinically apparent lesions. Interleukin-19 (IL-19) has been implicated in cytokine-responsive keratinocyte activation, whereas interleukin-37 (IL-37) has endogenous anti-inflammatory functions. Their superficial epidermal expression patterns in lesional and clinically non-lesional AD skin have not been extensively characterized within the same cohort. To compare

Indexed as

Dermatitis, AtopicEpidermisInterleukin-1InterleukinsAdolescentAdultCase-Control StudiesCross-Sectional StudiesFemaleGene Expression RegulationHumansMaleRNA, MessengerYoung AdultIL19 protein, humanIL37 protein, humanInterleukin-1InterleukinsRNA, Messengeratopic dermatitiscytokine regulationepidermisIL19IL37non-lesional skinRT-qPCRtape stripping

Identifiers

PMID42883983
PMCPMC13664781

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.